A carregar...
MEK1/2-ERK Pathway Alterations as a Therapeutic Target in Sporadic Alzheimer’s Disease: A Study in Senescence-Accelerated OXYS Rats
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia worldwide, with no cure. There is growing interest in mitogen-activated protein kinases (MAPKs) as possible pathogenesis-related therapeutic targets in AD. Previously, using senescence-accelera...
Na minha lista:
| Publicado no: | Antioxidants (Basel) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8300733/ https://ncbi.nlm.nih.gov/pubmed/34208998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antiox10071058 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|